Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

TRaaSer


5, rue Henri Desbruères
91030 EVRY Cedex – FRANCE
Email: contact@traaser.com

Artiguenave François: President & CSO
Site Web >
Traaser - Genopole's Company Traaser - Genopole's Company

Program Booster

#Health / Well-being

  • Genomics,
  • Personalized medicine,
  • Diagnosis,
  • e-health

Field of Activity


Software for biomedical data analysis

BACKGROUND

Traaser was created by genomics specialists to revolutionize medical practice, providing physicians with access to personalized medicine using innovative molecular diagnostic technologies.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

TIWI, the digital platform developed by Traaser, was designed to intelligently connect physicians and laboratories for the use of genomics. With TIWI:

  • Practitioners can order genetic tests, even without being specialists, learn about genetic diseases and diagnostic innovations.
  • Laboratories can access a larger customer base, reduce the number of incidents of non-compliance, and speed up genetic analyzes.

CUSTOMER REFERENCES / COLLABORATIONS / HIGLIGHTS

Traaser has established partnership contracts with major public health players in France and works in particular with AP-HP or the ORKiD sector, specializing in the management of genetic kidney diseases.

Traaser also collaborates with innovative partners in cancer research:

  • Transgene,
  • Institut Curie,
  • HAlioDX

COLLABORATIONS SOUGTH
Traaser is looking for health and financial partners to continue the development of its software platform in the various pathology fields (rare diseases, oncology, common diseases).

  • Further information

    1 Patent
    2 Softwares

    3 Staff Members

    Strengths

    An experienced team, proven know-how, innovative technologies.

    Innovation Assets

    Technology, network

Share
Genopole’s Companies

#Health / Well-being


In same field

DeepTope - Genopole's company

Deeptope

– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodies

Discover
Theranovir - Genopole's Company

Theranovir

Biotechnology, R&D, Drug development, oncology, obesity, infectious diseases

Discover
Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover
Innovhem - Entreprise génopolitaine

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover
Whitelab Genomics - Genopole's Company

WhiteLab Genomics

Artificial intelligence to optimize and accelerate the development of gene therapies

Discover
Vaccinopole - entreprise génopolitaine

Vaccinopole

Production of BCG vaccines and BCG-based cancer and inflammation treatments, preparation and distribution of fresh log-phase BCG cultures.

Discover
Synsight - Genopole's Company

Synsight

Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).

Discover
Sebia - Genopole's Company

Sebia

Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.

Discover
Santen - Genopole's Company

Santen

Santen SAS has developed its own sales force to commercialize ophthalmic products in France while Novagali Innovation Center is a center of excellence for Santen Group dedicated to research and development of innovative ophthalmic treatments for all segments of the eye.

Discover
Pharnext - Genopole's company

Pharnext SA

Pharnext develops new therapies and biomarkers based on network pharmacology with a proprietary discovery platform. The company is focused on pathologies with high unmet medical needs. These include neurodegenerative, orphan and common diseases (Charcot-Marie-Tooth disease Type 1A, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS)).

Discover
PEP-Therapy - Genopole's Company - logo 2021

PEP-Therapy

PEP-Therapy develops innovative peptides as targeted therapies in oncology. The company operates a unique therapeutic technology based on cell penetrating & interfering peptides (CP&IP). These innovative molecules penetrate cells and specifically block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.

Discover
LPS Biosciences - Genopole's company

LPS-BioSciences

LPS-BioSciences is specialized in bacterial endotoxins. It combines an exclusive proprietary technology for endotoxin production and characterization. and its acquired experience in the fields of vaccines, diagnostics, and the food industry.

Discover
Logo Integragen - Genopole's Company

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover
Généthon - Genopole's Laboratory

Généthon

Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.

Discover
Enterome - Genopole's company

Enterome

Enterome develops and commercializes therapies for disorders associated with disruption of the intestinal microbiota.

Discover
Endodiag - Genopole's company

Endodiag

Design, development and commercialization of medical devices and services for the diagnosis of endometriosis.

Discover
Enalees - Genopole's company

Enalees

Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

Discover
Algobiotech - Genopole's company

Algobiotech

Research and valorization of microalgae for cosmetic, nutraceutic and therapeutic applications.

Discover
AiiNTENSE - Genopole's company

AiiNTENSE

AiiNTENSE provides a complete cognitive assistance solution to improve the medical, ethical and economic management of patients in intensive care units.

Discover
logo abcell Bio - Genopole's Companie

ABCell-Bio

Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.

Discover
View all >
With the support from